SINGAPORE (Reuters) – The use of two influenza vaccines has been temporarily suspended as a precautionary measure following the deaths of some people received by South Korea in Singapore, the first countries to announce a public ban on vaccine use.
South Korea has reported 48 deaths as of Saturday following flu shots, but said it would continue with the state-run vaccination program, as they have no direct link between the deaths and the shots.
No deaths related to the influenza vaccine have been reported in Singapore to date, but the Ministry of Health and the Health Sciences Authority (HSA) said in a statement late Sunday night that Was kept.
The HSA is in contact with South Korean officials for more information as they investigate to determine if the death toll is related to influenza vaccination.
SKYKelflu Quadrivalent is manufactured by SK Biosciences of South Korea and distributed locally by AJ Biologics, while Vaxigripetra is manufactured by Sanofi and distributed locally by Sanofi Aventis.
The other two influenza vaccines in Singapore that have been brought to the Northern Hemisphere for the 2020/21 influenza season could continue to be used, health officials in Singapore said.
Report by Aradhana Arvindan in Singapore; Edited by Myong Kim and Richard Chang
.
